Latest filing published 05 Mar 2007 for HOLLIS EDEN PHARMACEUTICALS INC /DE/, €5,158.
No signal scores available.
Robert W. Weber discloses dealings in Hollis Eden Pharmaceuticals Inc /DE/ to SEC (Form 4). The record holds 27 filings, for trades running from 13 February 2006 to 5 March 2007.
No open-market purchase appears, only 21 sales worth €136k. The rest of the record consists of 1 share grant and 5 option exercises. Since January 2007: no purchases and 19 sales on the market.
The newest entry dates from 5 March 2007: an open-market sale of €1,220, in Hollis Eden Pharmaceuticals Inc /DE/. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 26 declarations